Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA) (TROPIX)
Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
A NA clinical study on Infertility, Female and Reproductive Sterility, this trial is actively recruiting participants. The trial is conducted by Instituto Valenciano de Infertilidad, IVI VALENCIA and has accumulated 4 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Oct 2025 — Present [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Oct 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto Valenciano de Infertilidad, IVI VALENCIA
For direct contact, visit the study record on ClinicalTrials.gov .